Orthofix Medical Inc (OFIX)
13.76
-0.46
(-3.24%)
USD |
NASDAQ |
May 31, 16:00
13.73
-0.03
(-0.21%)
After-Hours: 20:00
Orthofix Medical Enterprise Value: 607.60M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 607.60M |
| May 30, 2024 | 624.90M |
| May 29, 2024 | 633.53M |
| May 28, 2024 | 639.91M |
| May 24, 2024 | 650.04M |
| May 23, 2024 | 649.29M |
| May 22, 2024 | 638.03M |
| May 21, 2024 | 634.66M |
| May 20, 2024 | 657.92M |
| May 17, 2024 | 654.17M |
| May 16, 2024 | 658.30M |
| May 15, 2024 | 668.06M |
| May 14, 2024 | 659.05M |
| May 13, 2024 | 657.17M |
| May 10, 2024 | 640.66M |
| May 09, 2024 | 635.03M |
| May 08, 2024 | 650.42M |
| May 07, 2024 | 612.51M |
| May 06, 2024 | 596.38M |
| May 03, 2024 | 601.63M |
| May 02, 2024 | 588.11M |
| May 01, 2024 | 580.04M |
| April 30, 2024 | 579.10M |
| April 29, 2024 | 582.48M |
| April 26, 2024 | 578.73M |
| Date | Value |
|---|---|
| April 25, 2024 | 582.86M |
| April 24, 2024 | 600.12M |
| April 23, 2024 | 587.36M |
| April 22, 2024 | 582.11M |
| April 19, 2024 | 581.30M |
| April 18, 2024 | 578.31M |
| April 17, 2024 | 577.56M |
| April 16, 2024 | 584.30M |
| April 15, 2024 | 580.93M |
| April 12, 2024 | 589.53M |
| April 11, 2024 | 613.10M |
| April 10, 2024 | 601.88M |
| April 09, 2024 | 638.91M |
| April 08, 2024 | 624.70M |
| April 05, 2024 | 623.58M |
| April 04, 2024 | 622.08M |
| April 03, 2024 | 609.73M |
| April 02, 2024 | 596.27M |
| April 01, 2024 | 617.22M |
| March 31, 2024 | 634.43M |
| March 28, 2024 | 604.39M |
| March 27, 2024 | 595.79M |
| March 26, 2024 | 570.73M |
| March 25, 2024 | 568.48M |
| March 22, 2024 | 563.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
235.04M
Minimum
Oct 24 2022
983.16M
Maximum
Sep 25 2019
621.78M
Average
613.82M
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 119.63B |
| Perspective Therapeutics Inc | 680.29M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Catheter Precision Inc | 2.370M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.02M |
| Revenue (Quarterly) | 188.61M |
| Total Expenses (Quarterly) | 212.55M |
| EPS Diluted (Quarterly) | -0.95 |
| Gross Profit Margin (Quarterly) | 67.46% |
| Profit Margin (Quarterly) | -19.10% |
| Earnings Yield | -24.57% |
| Normalized Earnings Yield | -21.91 |